Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 190 participants.

Also called NCT01868646

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose supportive care
Phase
Phase 4
Enrolled
  • 190 participants (enrolled count) (from the registry)
Sponsor
Materia Medica Holding (from the registry)
Registry
  • NCT NCT01868646
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Russia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01868646. Randomized; quadruple masking; primary purpose supportive care. Start 2013-05-07 (actual); primary completion 2016-06-15 (actual). Results posted on 2019-03-04.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus
Condition
Type II Diabetes Mellitus
Intervention (Drug)
Subetta
Intervention (Drug)
Placebo
Lead sponsor
Materia Medica Holding (class: industry)

Record details

Record id
cardio:ct-nct01868646
Content hash
b65939b4b3b6092d9e1eaa2dbdbef20b9e875ae4603957e14dda9d481e677fb1